Human Phenotype Ontology

Hello! Guest! Please Login or Register! Clinician Mode

Examples Gene: MT-ND1, POLG, Region: M:1-1000 Variant: m.8993T>G, 1:g.10042757T>C rs3888511 MSCV_0000006, ClinVar: RCV000000015, Disease: Leigh syndrome, Phenotype: Retinopathy

Grandparent Node:
Abnormal circulating nucleobase concentration (HP:0010932)

Parent Node:
Abnormal circulating pyrimidine concentration (HP:0004353)

..Starting node
..Reduced orotidine 5-prime phosphate decarboxylase level (HP:0003267)

Term ID:

3267

Name:

Reduced orotidine 5-prime phosphate decarboxylase level

Synonym:

Orotidine-5-prime-phosphate decarboxylase defect

Definition:

An abnormal decrease in orotidine 5'-phosphate decarboxylase level.

Comments:

Reference:

HP:0003267

Genes and Diseases:

Child Nodes:

Sister Nodes:

Deficient excision of UV-induced pyrimidine dimers in DNA (HP:0003213)

obsolete Increased urinary orotic acid concentration (HP:0010928)

Reduced dihydropyrimidine dehydrogenase level (HP:0003654)

Uraciluria (HP:0012127)

Input	HPO ID	HPO term	Distance	Gene	Gene id entrez	HGNC ID	DiseaseId	DiseaseName	Frequency	ClinVar variants
HPO disease - gene - phenotype typical associations:
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003267	HP:0003267	Reduced orotidine 5-prime phosphate decarboxylase level	0	UMPS CL E G H	7372	12563	OMIM:258900	Orotic aciduria	.	135

Genes (1) :UMPS

Diseases (1) :OMIM:258900

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.